xAnts

Breakthrough in Heart Health: Experimental Drug Shows Promise in Delaying Valve Disease Progression

In a groundbreaking clinical trial, an experimental drug initially developed by Sanofi and now being advanced by the Mayo Clinic has demonstrated significant potential in slowing the progression of aortic valve stenosis, a prevalent heart condition. ...undefined